These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 37821131)

  • 1. Potassium canrenoate in brain-dead organ donors: a randomised controlled clinical trial protocol (CANREO-PMO).
    Belarif L; Girerd S; Jaisser F; Lepage X; Merckle L; Duarte K; Girerd N; Guerci P
    BMJ Open; 2023 Oct; 13(10):e073831. PubMed ID: 37821131
    [TBL] [Abstract][Full Text] [Related]  

  • 2. EPURE Transplant (Eplerenone in Patients Undergoing Renal Transplant) study: study protocol for a randomized controlled trial.
    Girerd S; Frimat L; Ducloux D; Le Meur Y; Mariat C; Moulin B; Mousson C; Rieu P; Dali-Youcef N; Merckle L; Lepage X; Rossignol P; Girerd N; Jaisser F
    Trials; 2018 Oct; 19(1):595. PubMed ID: 30376884
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mineralocorticoid receptor antagonists in kidney transplantation: time to consider?
    Girerd S; Jaisser F
    Nephrol Dial Transplant; 2018 Dec; 33(12):2080-2091. PubMed ID: 29672718
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of targeted hypothermia in expanded-criteria organ donors on recipient kidney-graft function: study protocol for a multicentre randomised controlled trial (HYPOREME).
    Brulé N; Canet E; Péré M; Feuillet F; Hourmant M; Asehnoune K; Rozec B; Duveau A; Dube L; Pierrot M; Humbert S; Tirot P; Boyer JM; Martin-Lefevre L; Labadie F; Robert R; Benard T; Kerforne T; Thierry A; Lesieur O; Vincent JF; Lesouhaitier M; Larmet R; Vigneau C; Goepp A; Bouju P; Quentin C; Egreteau PY; Huet O; Renault A; Le Meur Y; Venhard JC; Buchler M; Michel O; Voellmy MH; Herve F; Schnell D; Courte A; Glotz D; Amrouche L; Hazzan M; Kamar N; Moal V; Bourenne J; Le Quintrec-Donnette M; Morelon E; Boulain T; Grimbert P; Heng AE; Merville P; Garin A; Hiesse C; Fermier B; Mousson C; Guyot-Colosio C; Bouvier N; Rerolle JP; Durrbach A; Drouin S; Caillard S; Frimat L; Girerd S; Albano L; Rostaing L; Bertrand D; Hertig A; Westeel PF; Montini F; Delpierre E; Dorez D; Alamartine E; Ouisse C; Sebille V; Reignier J
    BMJ Open; 2022 Mar; 12(3):e052845. PubMed ID: 35351701
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Remote ischaemic conditioning on recipients of deceased renal transplants, effect on immediate and extended kidney graft function: a multicentre, randomised controlled trial protocol (CONTEXT).
    Krogstrup NV; Oltean M; Bibby BM; Nieuwenhuijs-Moeke GJ; Dor FJ; Birn H; Jespersen B
    BMJ Open; 2015 Aug; 5(8):e007941. PubMed ID: 26297360
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Randomised sham-controlled double-blind trial evaluating remote ischaemic preconditioning in solid organ transplantation: a study protocol for the RIPTRANS trial.
    Uutela A; Helanterä I; Lemström K; Passov A; Syrjälä S; Åberg F; Mäkisalo H; Nordin A; Lempinen M; Sallinen V;
    BMJ Open; 2020 Nov; 10(11):e038340. PubMed ID: 33199419
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Calcineurin Inhibitor in NEuRoloGically deceased donors to decrease kidney delayed graft function study: study protocol of the CINERGY Pilot randomised controlled trial.
    D'Aragon F; Selzner M; Breau R; Masse MH; Lamontagne F; Masse M; Chassé M; Carrier FM; Cardinal H; Chaudhury P; Weiss M; Lauzier F; Turgeon AF; Frenette AJ; Bolduc B; Ducharme A; Lamarche C; Couture E; Holdsworth S; Bertholz L; Talbot H; Slessarev M; Luke P; Boyd JG; Shamseddin MK; Burns KEA; Zaltzman J; English S; Knoll G; Dhanani S; Healey A; Hanna S; Rochwerg B; Oczkowski SJW; Treleaven D; Meade M;
    BMJ Open; 2024 Jun; 14(6):e086777. PubMed ID: 38871657
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Acute renal failure of the donor in encephalic death: A real contraindication to kidney transplantation?].
    Fosse A; Karam G; Kerleau C; Perrouin-Verbe ; Rigaud J; Baron M; Mesnard B; Hedhli O; Ville S; De Vergie S; Chelghaf I; Loubersac T; Boutin JM; Faivre d'Arcier B; Bruyère F; Cantarovich D; Branchereau J
    Prog Urol; 2021; 31(8-9):519-530. PubMed ID: 33478867
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypothermia for expanded criteria organ donors in kidney transplantation in France (HYPOREME): a multicentre, randomised controlled trial.
    HYPOREME Trial Group
    Lancet Respir Med; 2024 Jun; ():. PubMed ID: 38876137
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ramipril versus placebo in kidney transplant patients with proteinuria: a multicentre, double-blind, randomised controlled trial.
    Knoll GA; Fergusson D; Chassé M; Hebert P; Wells G; Tibbles LA; Treleaven D; Holland D; White C; Muirhead N; Cantarovich M; Paquet M; Kiberd B; Gourishankar S; Shapiro J; Prasad R; Cole E; Pilmore H; Cronin V; Hogan D; Ramsay T; Gill J
    Lancet Diabetes Endocrinol; 2016 Apr; 4(4):318-26. PubMed ID: 26608067
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of cyclosporine A pretreatment of deceased organ donors on kidney graft function (Cis-A-rein): study protocol for a randomized controlled trial.
    Orban JC; Fontaine E; Cassuto E; Baumstarck K; Leone M; Constantin JM; Ichai C;
    Trials; 2018 Apr; 19(1):231. PubMed ID: 29665840
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early remote ischaemic preconditioning leads to sustained improvement in allograft function after live donor kidney transplantation: long-term outcomes in the REnal Protection Against Ischaemia-Reperfusion in transplantation (REPAIR) randomised trial.
    Veighey KV; Nicholas JM; Clayton T; Knight R; Robertson S; Dalton N; Harber M; Watson CJE; De Fijter JW; Loukogeorgakis S; MacAllister R
    Br J Anaesth; 2019 Nov; 123(5):584-591. PubMed ID: 31521337
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Performance of the 2021 Race-Free CKD-EPI Creatinine- and Cystatin C-Based Estimated GFR Equations Among Kidney Transplant Recipients.
    Hundemer GL; White CA; Norman PA; Knoll GA; Tangri N; Sood MM; Hiremath S; Burns KD; McCudden C; Akbari A
    Am J Kidney Dis; 2022 Oct; 80(4):462-472.e1. PubMed ID: 35588905
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A randomised, double-blind, placebo-controlled, pilot trial of intravenous plasma purified alpha-1 antitrypsin for SARS-CoV-2-induced Acute Respiratory Distress Syndrome: a structured summary of a study protocol for a randomised, controlled trial.
    McEvoy NL; Clarke JL; Mc Elvaney OJ; Mc Elvaney OF; Boland F; Hyland D; Geoghegan P; Donnelly K; Friel O; Cullen A; Collins AM; Fraughen D; Martin-Loeches I; Hennessy M; Laffey JG; Mc Elvaney NG; Curley GF
    Trials; 2021 Apr; 22(1):288. PubMed ID: 33874981
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A phase I/II, double-blind, placebo-controlled study assessing safety and efficacy of C1 esterase inhibitor for prevention of delayed graft function in deceased donor kidney transplant recipients.
    Jordan SC; Choi J; Aubert O; Haas M; Loupy A; Huang E; Peng A; Kim I; Louie S; Ammerman N; Najjar R; Puliyanda D; Vo A
    Am J Transplant; 2018 Dec; 18(12):2955-2964. PubMed ID: 29637714
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Race-free estimated glomerular filtration rate equation in kidney transplant recipients: development and validation study.
    Raynaud M; Al-Awadhi S; Juric I; Divard G; Lombardi Y; Basic-Jukic N; Aubert O; Dubourg L; Masson I; Mariat C; Prié D; Pernin V; Le Quintrec M; Larson TS; Stegall MD; Bikbov B; Ruggenenti P; Mesnard L; Ibrahim HN; Nielsen MB; Matas AJ; Nankivell BJ; Benjamens S; Pol RA; Bakker SJL; Jouven X; Legendre C; Kamar N; Smith BH; Wadei HM; Durrbach A; Vincenti F; Remuzzi G; Lefaucheur C; Bentall AJ; Loupy A
    BMJ; 2023 May; 381():e073654. PubMed ID: 37257905
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A double-blind randomised controlled investigation into the efficacy of Mirococept (APT070) for preventing ischaemia reperfusion injury in the kidney allograft (EMPIRIKAL): study protocol for a randomised controlled trial.
    Kassimatis T; Qasem A; Douiri A; Ryan EG; Rebollo-Mesa I; Nichols LL; Greenlaw R; Olsburgh J; Smith RA; Sacks SH; Drage M
    Trials; 2017 Jun; 18(1):255. PubMed ID: 28587616
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Testing the efficacy and safety of BIO101, for the prevention of respiratory deterioration, in patients with COVID-19 pneumonia (COVA study): a structured summary of a study protocol for a randomised controlled trial.
    Dioh W; Chabane M; Tourette C; Azbekyan A; Morelot-Panzini C; Hajjar LA; Lins M; Nair GB; Whitehouse T; Mariani J; Latil M; Camelo S; Lafont R; Dilda PJ; Veillet S; Agus S
    Trials; 2021 Jan; 22(1):42. PubMed ID: 33430924
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Double-blind, randomized, controlled, trial to assess the efficacy of allogenic mesenchymal stromal cells in patients with acute respiratory distress syndrome due to COVID-19 (COVID-AT): A structured summary of a study protocol for a randomised controlled trial.
    Payares-Herrera C; Martínez-Muñoz ME; Vallhonrat IL; de Molina RM; Torres MP; Trisan A; de Diego IS; Alonso R; Zafra R; Donaire T; Sánchez R; Rubio JJ; Duarte Palomino RF; Solá CA
    Trials; 2021 Jan; 22(1):9. PubMed ID: 33407777
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.